The effect of treatment on serum levels of soluble intercellular adhesion molecules and tumour necrosis factor-receptor 1 in psoriasis.
Kirby
B
B
Boffa
M J
MJ
Nayak
N
N
Gallatin
W M
WM
Martin
S
S
Griffiths
C E
CE
D000328:Adult; D015703:Antigens, CD / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D015815:Cell Adhesion Molecules / Q000097:blood*; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000097:blood / Q000628:therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood*; D047888:Receptors, Tumor Necrosis Factor, Type I
D015703:Antigens, CD; D015415:Biomarkers; D015815:Cell Adhesion Molecules; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I